ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2024

Erlotinib suppresses tumorigenesis in a mouse model of colitis-associated cancer.

Max Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.